Sie suchten nach: Fura-FF, pentapotassium salt [Fura-2FF, pentapotassium salt]
146 results were found
Sanborn Manufacturing Facility
/cms/it/sanborn_manufacturing_facility
Sanborn Manufacturing Facility The HEPES manufacturing suite at our 60000 sq. ft. manufacturing facility in Sanborn NY USA. Core Capabilities Custom manufacturing of biological buffers amino acid derivatives and custom antibiotic solutions Industr...
Upstream Gene Therapy Products & Solutions in Bioprocessing
/cms/it/bioprocessing_gene_therapy_upstream_processing
Upstream Gene Therapy Products & Solutions in Bioprocessing Achieve optimal generation of gene therapy vectors with our non-viral transfection and viral transduction products. Avantor® can provide culture systems that support processes development...
Upstream Gene Therapy Products & Solutions in Bioprocessing
/cms/fr/bioprocessing_gene_therapy_upstream_processing
Upstream Gene Therapy Products & Solutions in Bioprocessing Achieve optimal generation of gene therapy vectors with our non-viral transfection and viral transduction products. Avantor® can provide culture systems that support processes development...
ls ge29064277 20131210235846
/m-ch.vwr.com/it_CH/images/ls_ge29064277_20131210235846.pdf
imagination at work Application note 29-0642-77 AB Chromatography systems Purification of an N-terminal histidine-tagged protein using ÄKTA™ start ÄKTA start eliminates the hassles of manual protein purification handling such as loading large samp...
Upstream Gene Therapy Products & Solutions in Bioprocessing
/cms/de/bioprocessing_gene_therapy_upstream_processing
Upstream Gene Therapy Products & Solutions in Bioprocessing Achieve optimal generation of gene therapy vectors with our non-viral transfection and viral transduction products. Avantor® can provide culture systems that support processes development...
Sanborn Manufacturing Facility
/cms/de/sanborn_manufacturing_facility
Sanborn Manufacturing Facility The HEPES manufacturing suite at our 60000 sq. ft. manufacturing facility in Sanborn NY USA. Core Capabilities Custom manufacturing of biological buffers amino acid derivatives and custom antibiotic solutions Industr...
Sanborn Manufacturing Facility
/cms/fr/sanborn_manufacturing_facility
Sanborn Manufacturing Facility The HEPES manufacturing suite at our 60000 sq. ft. manufacturing facility in Sanborn NY USA. Core Capabilities Custom manufacturing of biological buffers amino acid derivatives and custom antibiotic solutions Industr...
Final fill for mAbs
/cms/de/bioprocessing_mabs_final_fill
Final fill for mAbs Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO Cla...
Downstream purification for recombinant proteins
/cms/de/bioprocessing_recombinant_proteins_downstream_purification
Downstream purification for recombinant proteins With more than 30 years of chromatography experience developed products and services we have every solution to meet your needs. Our J.T.Baker® brand BAKERBOND™ chromatography resins have been used s...
Montreal Manufacturing Facility
/cms/de/montreal_manufacturing_facility
Montreal Manufacturing Facility The off-loading manifold at our Montreal QC manufacturing facility which includes 8600 sq. ft. for manufacturing 2200 sq. ft. for quality control and a 22800 sq. ft. warehouse. Core Capabilities Production of labora...
Final fill for mAbs
/cms/it/bioprocessing_mabs_final_fill
Final fill for mAbs Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO Cla...
Final fill for cell therapy
/cms/fr/bioprocessing_cell_therapy_final_fill
Final fill for cell therapy The cell therapy drug product is configured in different ways depending on the required delivery of the cells/tissues. For example delivery of chondrocytes for cartilage repair is administered by an injection. Expanded ...
Upstream processing for cell therapy
/cms/de/bioprocessing_cell_therapy_upstream_processing
Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...
Final fill for vaccines
/cms/it/bioprocessing_vaccines_final_fill
Final fill for vaccines Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO...
Final fill for vaccines
/cms/de/bioprocessing_vaccines_final_fill
Final fill for vaccines Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO...
Final fill for vaccines
/cms/fr/bioprocessing_vaccines_final_fill
Final fill for vaccines Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO...
49 - 64 of 146